Eli Lilly And Company Earnings

Eli Lilly And Company’s revenue jumped 37.64% since last year same period to $15557.7Mn in the Q2 2025. On a quarterly growth basis, Eli Lilly And Company has generated 22.23% jump in its revenue since last 3-months.

Eli Lilly And Company’s net profit jumped 90.78% since last year same period to $5660.5Mn in the Q2 2025. On a quarterly growth basis, Eli Lilly And Company has generated 105.14% jump in its net profits since last 3-months.

Eli Lilly And Company’s net profit margin jumped 38.6% since last year same period to 36.38% in the Q2 2025. On a quarterly growth basis, Eli Lilly And Company has generated 67.84% jump in its net profit margins since last 3-months.

Eli Lilly And Company’s earning per share (EPS) estimates for the current quarter stand at 6.37 - a 13.95% jump from last quarter’s estimates.

Eli Lilly And Company’s earning per share (EPS) estimates for the current year stand at 6.37.

Eli Lilly And Company’s earning per share (EPS) jumped 60.97% since last year same period to 6.31 in the Q2 2025. This indicates that the Eli Lilly And Company has generated 60.97% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Eli Lilly And Company declared 1.5 dividend per share during the earnings announcement for Q2 2025.